Vaccine News and Research

Latest Vaccine News and Research

Vaccination programs combined with physical distancing could contain COVID-19 resurgence

A combination of robust vaccination programs and strict physical distancing rules could avoid recurring peaks of COVID-19 without the need to rely on stay-at-home restrictions, according to a new study by epidemiologists and demographers from WorldPop at the University of Southampton, in collaboration with The Chinese University of Hong Kong.

20 Feb 2021

Interval between doses of Oxford COVID-19 vaccine can be safely extended to 3 months, suggests study

A 3-month interval between doses of the Oxford COVID-19 vaccine results in higher vaccine efficacy than a 6-week interval, with the first dose offering 76% protection in the 3 months between doses.

20 Feb 2021

Review provides an overview of immunogenicity profiles of leading SARS-CoV-2 vaccine candidates

In a new Review, P.J. Klasse and colleagues present an extensive overview of the immunogenicity profiles of several leading SARS-CoV-2 vaccine candidates, including several developed under the auspices of the U.S. Government's "Operation Warp Speed" program, as well as leading candidates from China and Russia.

20 Feb 2021

Intranasal COVID-19 vaccine candidate preclinically tested at UAB expected to start clinical trial

The Altimmune Inc. vaccine candidate that was tested preclinically at the University of Alabama at Birmingham last year is expected to start patient enrollment for its Phase 1 clinical trial next week.

20 Feb 2021

Experts advocate for increased diversity in vaccine clinical trials

A team of scientific experts from across the U.S. and Puerto Rico are advocating for increased diversity in vaccine trials after publishing a new report that highlights a decade's worth of disparities.

20 Feb 2021

New single-payer bill intensifies Newsom’s political peril

A group of Democratic state lawmakers introduced legislation Friday to create a single-payer health care system to cover all Californians, immediately defining the biggest health policy debate of the year and putting enormous political pressure on Gov. Gavin Newsom.

19 Feb 2021

To vaccinate veterans, health care workers must cross mountains, plains and tundra

A Learjet 31 took off before daybreak from Helena Regional Airport in Montana, carrying six Veterans Affairs medical providers and 250 doses of historic cargo cradled in a plug-in cooler designed to minimize breakage.

19 Feb 2021

Spurred by pandemic, Little Shell Tribe fast-tracks its health service debut

Linda Watson draped a sweater with the words "Little Shell Chippewa Tribe" over her as she received the newly recognized tribal nation's first dose of covid-19 vaccine.

19 Feb 2021

Companies pan for marketing gold in vaccines

For a decade, Jennifer Crow has taken care of her elderly parents, who have multiple sclerosis. After her father had a stroke in December, the family got serious in its conversations with a retirement community — and learned that one service it offered was covid-19 vaccination.

19 Feb 2021

Live attenuated SARS-CoV-2 vaccine candidate shows protective efficacy in vivo

A new preprint on the bioRxiv* server describes the development of a live attenuated vaccine candidate to counter the growing threat of the COVID-19 pandemic.

19 Feb 2021

Chicken-derived antibody shows potent neutralizing capacity against SARS-CoV-2 in vitro

Researchers report on a Chicken-derived antibody against SARS-CoV-2, offering preliminary data on a potential therapeutic for COVID-19 warranting further research.

19 Feb 2021

How does the SARS-CoV-2 E484K mutation increase viral fitness?

How do mutations benefit SARS-CoV-2? To explore this, a team of researchers from China took a closer look at the physical interactions that occur between the proteins after viral mutation.

19 Feb 2021

Cologne University professor heads new consortium on EU vaccine research network

The European Union is funding the establishment of the new vaccine research network VACCELERATE with a total of 12 million euros for three years.

18 Feb 2021

Immune response to SARS-CoV-2 may be limited by a set of genes

Neutralizing antibodies develop within two weeks of a SARS-CoV-2 infection, but their durability and intensity can vary by individual, prompting concerns about the prospects of long-lasting immunity and efficacy of COVID-19 vaccines.

18 Feb 2021

Zambia study casts doubt on the assumption that COVID-19 skipped Africa

A new study concluding out of Lusaka, Zambia last summer has found that as many as 19% (almost 1 in 5) of recently-deceased people tested positive for COVID-19.

18 Feb 2021

O-glycosylation of SARS-CoV-2 spike protein in insect and human cell lines

The mapping of O-glycosites requires instruments that can support electron transfer dissociation (ETD) fragmentation. In a new study published on the bioRxiv preprint server, researchers report their results on whether O-glycosylation patterns affect immunogens for vaccine development.

18 Feb 2021

Could measles virus vectors be used for a new COVID-19 vaccine?

A research team at the Institut Pasteur in France describes the successful development of such a vaccine utilizing a measles virus vector.

18 Feb 2021

Restricting testing to 'classic triad' of symptoms may have missed some COVID-19 cases

Extending the symptoms that trigger a PCR test for COVID-19 could help detect around a third more cases of the disease.

18 Feb 2021

KHN’s ‘What the Health?’: Open enrollment, one more time

An estimated 9 million Americans eligible for free or reduced premium health insurance under the Affordable Care Act have a second chance to sign up for 2021 coverage, since the Biden administration reopened enrollment on healthcare.gov and states that run their own marketplaces followed suit.

18 Feb 2021

How have COVID-19 pandemic school closures impacted the health of children globally?

A new study by researchers in the US and the UK explores the damage caused by school closures to educational progress, health, and well-being in children and young people globally.

18 Feb 2021

Vaccine News and Research

Latest Vaccine News and Research

Vaccination programs combined with physical distancing could contain COVID-19 resurgence

Interval between doses of Oxford COVID-19 vaccine can be safely extended to 3 months, suggests study

Review provides an overview of immunogenicity profiles of leading SARS-CoV-2 vaccine candidates

Intranasal COVID-19 vaccine candidate preclinically tested at UAB expected to start clinical trial

Experts advocate for increased diversity in vaccine clinical trials

New single-payer bill intensifies Newsom’s political peril

To vaccinate veterans, health care workers must cross mountains, plains and tundra

Spurred by pandemic, Little Shell Tribe fast-tracks its health service debut

Companies pan for marketing gold in vaccines

Live attenuated SARS-CoV-2 vaccine candidate shows protective efficacy in vivo

Chicken-derived antibody shows potent neutralizing capacity against SARS-CoV-2 in vitro

How does the SARS-CoV-2 E484K mutation increase viral fitness?

Cologne University professor heads new consortium on EU vaccine research network

Immune response to SARS-CoV-2 may be limited by a set of genes

Zambia study casts doubt on the assumption that COVID-19 skipped Africa

O-glycosylation of SARS-CoV-2 spike protein in insect and human cell lines

Could measles virus vectors be used for a new COVID-19 vaccine?

Restricting testing to 'classic triad' of symptoms may have missed some COVID-19 cases

KHN’s ‘What the Health?’: Open enrollment, one more time

How have COVID-19 pandemic school closures impacted the health of children globally?

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in